Sarepta Therapeutics, Inc. 4
4 · Sarepta Therapeutics, Inc. · Filed Sep 21, 2016
Insider Transaction Report
Form 4
Aphale Jayant
SVP Technical Operations
Transactions
- Exercise/Conversion
Incentive Stock Options (right to buy)
2016-09-19$4.62/sh−25,000$115,500→ 61,580 totalExercise: $4.62From: 2012-12-22Exp: 2021-12-22→ Common Stock (25,000 underlying) - Exercise/Conversion
Non-Qualified Stock Options (right to buy)
2016-09-19$4.62/sh−10,000$46,200→ 3,420 totalExercise: $4.62From: 2012-12-22Exp: 2021-12-22→ Common Stock (10,000 underlying) - Exercise/Conversion
Common Stock
2016-09-19$4.62/sh+10,000$46,200→ 21,490 total - Sale
Common Stock
2016-09-19$50.00/sh−10,000$500,000→ 11,490 total - Exercise/Conversion
Common Stock
2016-09-19$4.62/sh+25,000$115,500→ 36,490 total - Sale
Common Stock
2016-09-19$50.00/sh−25,000$1,250,000→ 11,490 total
Footnotes (1)
- [F1]This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person, on December 11, 2015, accordingly, the reporting person had no discretion with regards to the timing of the transaction.